BIOXCEL THERAPEUTICS INC
BTAI·09075P204·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G
BTAI (BIOXCEL THERAPEUTICS INC) is held by 27 institutional investors as of Q1 2026. Largest holders: MILLENNIUM MANAGEMENT LLC ($2.6M), OAKTREE CAPITAL MANAGEMENT LP ($323,193), GEODE CAPITAL MANAGEMENT, LLC ($308,725). Net institutional sentiment: Mixed.
27
Holders
Avg rating(7 Elite)
$4.6M
Total Value
57% (32)
Fund Consensus
13 buying - 10 selling
Who's Trading
ActivistARArmistice Capital, LLC7.0%May 15, 2026
InsiderMVMehta VimalExercise 18K shMay 1, 2026
InsiderRJRodriguez JavierExercise 9K shMay 1, 2026
InsiderSISteinhart Richard IExercise 9K shMay 1, 2026
InsiderYFYocca FrankExercise 9K shMay 1, 2026
ActivistQIQatar Investment Authority0.6%Mar 30, 2026
ActivistICIntegrated Core Strategies (US) LLC8.4%Feb 9, 2026
ActivistOAOaktree Fund Advisors, LLC0.8%May 15, 2025
13F: Insider & Congress:
Showing 1-20 of 32
1 / 2
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer